Please login to the form below

Not currently logged in
Email:
Password:

Durbin appoints US business development principal

Todd Galles now takes up the role on a permanent basis

Durbin Todd GallesSpecialist medical supplier Durbin has appointed Todd Galles as its business development principal in the US in a permanent capacity.

Galles first joined the UK-headquartered firm in 2014, serving as its US representative in a part-time role, and will now be responsible for growing its clinical trial supply and managed access business there.

He brings over 30 years of sales, marketing and business development experience in the pharma and biotech industries, and has held a number of executive management roles during this time.

Prior to joining Durbin, Galles served as director of business development at C3 Research Associates, business development US liaison for Japanese contract research organisation CMIC, and business development director at US firm BDC.

He also brings experience from dermatology CRO bioskin, medical device and biotech CRO Boston Biomedical Associates, and clinical and data management firm ProPharma Group.

Robert Donnell, head of business development at Durbin, said: “Todd has supported business development outreach in the US part-time for Durbin for more than two years, so now we're delighted to have him on-board full-time.

“Todd brings a huge amount of experience and enthusiasm to the role, and I look forward to continuing to work with him to develop and grow our US business.”

26th September 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics